Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 49

1.

Blood oxytocin concentration positively predicts contagious yawning behavior in children with autism spectrum disorder.

Mariscal MG, Oztan O, Rose SM, Libove RA, Jackson LP, Sumiyoshi RD, Trujillo TH, Carson DS, Phillips JM, Garner JP, Hardan AY, Parker KJ.

Autism Res. 2019 Aug;12(8):1156-1161. doi: 10.1002/aur.2135. Epub 2019 May 27.

PMID:
31132232
2.

A randomized placebo-controlled pilot trial shows that intranasal vasopressin improves social deficits in children with autism.

Parker KJ, Oztan O, Libove RA, Mohsin N, Karhson DS, Sumiyoshi RD, Summers JE, Hinman KE, Motonaga KS, Phillips JM, Carson DS, Fung LK, Garner JP, Hardan AY.

Sci Transl Med. 2019 May 8;11(491). pii: eaau7356. doi: 10.1126/scitranslmed.aau7356. Epub 2019 May 1.

PMID:
31043522
3.

Intranasal oxytocin treatment for social deficits and biomarkers of response in children with autism.

Parker KJ, Oztan O, Libove RA, Sumiyoshi RD, Jackson LP, Karhson DS, Summers JE, Hinman KE, Motonaga KS, Phillips JM, Carson DS, Garner JP, Hardan AY.

Proc Natl Acad Sci U S A. 2017 Jul 25;114(30):8119-8124. doi: 10.1073/pnas.1705521114. Epub 2017 Jul 10.

4.

The effects of intranasal oxytocin in opioid-dependent individuals and healthy control subjects: a pilot study.

Woolley JD, Arcuni PA, Stauffer CS, Fulford D, Carson DS, Batki S, Vinogradov S.

Psychopharmacology (Berl). 2016 Jul;233(13):2571-80. doi: 10.1007/s00213-016-4308-8. Epub 2016 May 3.

PMID:
27137199
5.

Oxytocin receptor: Expression in the trigeminal nociceptive system and potential role in the treatment of headache disorders.

Tzabazis A, Mechanic J, Miller J, Klukinov M, Pascual C, Manering N, Carson DS, Jacobs A, Qiao Y, Cuellar J, Frey WH 2nd, Jacobs D, Angst M, Yeomans DC.

Cephalalgia. 2016 Sep;36(10):943-50. doi: 10.1177/0333102415618615. Epub 2015 Nov 20.

PMID:
26590611
6.

Improving Research Standards to Restore Trust in Intranasal Oxytocin.

Carson DS, Yuan H, Labuschagne I.

Biol Psychiatry. 2016 Apr 15;79(8):e53-4. doi: 10.1016/j.biopsych.2015.08.031. Epub 2015 Sep 3. No abstract available.

PMID:
26435223
7.

Arginine Vasopressin Is a Blood-Based Biomarker of Social Functioning in Children with Autism.

Carson DS, Garner JP, Hyde SA, Libove RA, Berquist SW, Hornbeak KB, Jackson LP, Sumiyoshi RD, Howerton CL, Hannah SL, Partap S, Phillips JM, Hardan AY, Parker KJ.

PLoS One. 2015 Jul 22;10(7):e0132224. doi: 10.1371/journal.pone.0132224. eCollection 2015.

8.

Oxytocin treatment for amphetamine-induced social impairments.

Carson DS.

J Neurosci. 2014 Oct 29;34(44):14503-5. doi: 10.1523/JNEUROSCI.3509-14.2014. No abstract available.

9.

Cerebrospinal fluid and plasma oxytocin concentrations are positively correlated and negatively predict anxiety in children.

Carson DS, Berquist SW, Trujillo TH, Garner JP, Hannah SL, Hyde SA, Sumiyoshi RD, Jackson LP, Moss JK, Strehlow MC, Cheshier SH, Partap S, Hardan AY, Parker KJ.

Mol Psychiatry. 2015 Sep;20(9):1085-90. doi: 10.1038/mp.2014.132. Epub 2014 Nov 4.

PMID:
25349162
10.

Commentary on Heinzerling et‚ÄČal. (2014): a growing methamphetamine dependence therapeutics graveyard.

Carson DS, Taylor ER.

Addiction. 2014 Nov;109(11):1887-8. doi: 10.1111/add.12709. No abstract available.

PMID:
25297959
11.

Plasma vasopressin concentrations positively predict cerebrospinal fluid vasopressin concentrations in human neonates.

Carson DS, Howerton CL, Garner JP, Hyde SA, Clark CL, Hardan AY, Penn AA, Parker KJ.

Peptides. 2014 Nov;61:12-6. doi: 10.1016/j.peptides.2014.08.003. Epub 2014 Aug 19.

PMID:
25148831
12.

Plasma oxytocin concentrations and OXTR polymorphisms predict social impairments in children with and without autism spectrum disorder.

Parker KJ, Garner JP, Libove RA, Hyde SA, Hornbeak KB, Carson DS, Liao CP, Phillips JM, Hallmayer JF, Hardan AY.

Proc Natl Acad Sci U S A. 2014 Aug 19;111(33):12258-63. doi: 10.1073/pnas.1402236111. Epub 2014 Aug 4.

13.

Lithium carbonate in the management of cannabis withdrawal: a randomized placebo-controlled trial in an inpatient setting.

Johnston J, Lintzeris N, Allsop DJ, Suraev A, Booth J, Carson DS, Helliwell D, Winstock A, McGregor IS.

Psychopharmacology (Berl). 2014 Dec;231(24):4623-36. doi: 10.1007/s00213-014-3611-5. Epub 2014 Jun 1.

PMID:
24880749
14.

Plasma oxytocin concentrations are lower in depressed vs. healthy control women and are independent of cortisol.

Yuen KW, Garner JP, Carson DS, Keller J, Lembke A, Hyde SA, Kenna HA, Tennakoon L, Schatzberg AF, Parker KJ.

J Psychiatr Res. 2014 Apr;51:30-6. doi: 10.1016/j.jpsychires.2013.12.012. Epub 2013 Dec 28.

15.

A brief history of oxytocin and its role in modulating psychostimulant effects.

Carson DS, Guastella AJ, Taylor ER, McGregor IS.

J Psychopharmacol. 2013 Mar;27(3):231-47. doi: 10.1177/0269881112473788. Epub 2013 Jan 23. Review.

PMID:
23348754
16.

Preliminary evidence for lowered basal cortisol in a naturalistic sample of methamphetamine polydrug users.

Carson DS, Bosanquet DP, Carter CS, Pournajafi-Nazarloo H, Blaszczynski A, McGregor IS.

Exp Clin Psychopharmacol. 2012 Dec;20(6):497-503. doi: 10.1037/a0029976. Epub 2012 Oct 15.

PMID:
23066858
17.

Adolescent oxytocin exposure causes persistent reductions in anxiety and alcohol consumption and enhances sociability in rats.

Bowen MT, Carson DS, Spiro A, Arnold JC, McGregor IS.

PLoS One. 2011;6(11):e27237. doi: 10.1371/journal.pone.0027237. Epub 2011 Nov 16.

18.

Systemically administered oxytocin decreases methamphetamine activation of the subthalamic nucleus and accumbens core and stimulates oxytocinergic neurons in the hypothalamus.

Carson DS, Hunt GE, Guastella AJ, Barber L, Cornish JL, Arnold JC, Boucher AA, McGregor IS.

Addict Biol. 2010 Oct;15(4):448-63. doi: 10.1111/j.1369-1600.2010.00247.x. Epub 2010 Aug 23.

PMID:
20731630
19.

Intranasal arginine vasopressin enhances the encoding of happy and angry faces in humans.

Guastella AJ, Kenyon AR, Alvares GA, Carson DS, Hickie IB.

Biol Psychiatry. 2010 Jun 15;67(12):1220-2. doi: 10.1016/j.biopsych.2010.03.014. Epub 2010 May 5.

PMID:
20447617
20.

Disaster 101: a novel approach to disaster medicine training for health professionals.

Scott LA, Carson DS, Greenwell IB.

J Emerg Med. 2010 Aug;39(2):220-6. doi: 10.1016/j.jemermed.2009.08.064. Epub 2010 Jan 15.

PMID:
20079997
21.

Oxytocin decreases methamphetamine self-administration, methamphetamine hyperactivity, and relapse to methamphetamine-seeking behaviour in rats.

Carson DS, Cornish JL, Guastella AJ, Hunt GE, McGregor IS.

Neuropharmacology. 2010 Jan;58(1):38-43. doi: 10.1016/j.neuropharm.2009.06.018. Epub 2009 Jun 26.

PMID:
19560473
22.

A randomized controlled trial of intranasal oxytocin as an adjunct to exposure therapy for social anxiety disorder.

Guastella AJ, Howard AL, Dadds MR, Mitchell P, Carson DS.

Psychoneuroendocrinology. 2009 Jul;34(6):917-23. doi: 10.1016/j.psyneuen.2009.01.005. Epub 2009 Feb 25.

PMID:
19246160
23.

South Carolina Area Health Education Consortium Disaster Preparedness and Response Training Network: an emerging partner in preparedness training.

Kennedy B, Carson DS, Garr D.

J Public Health Manag Pract. 2009 Mar;15(2 Suppl):S13-9. doi: 10.1097/01.PHH.0000345980.49798.d2.

PMID:
19202395
24.

Does oxytocin influence the early detection of angry and happy faces?

Guastella AJ, Carson DS, Dadds MR, Mitchell PB, Cox RE.

Psychoneuroendocrinology. 2009 Feb;34(2):220-5. doi: 10.1016/j.psyneuen.2008.09.001. Epub 2008 Oct 9.

PMID:
18848401
25.

The gaping hole: physicians are missing from the front line of disaster preparedness training.

Shealy RM, Simpson WM Jr, Lee FW, Best CL, Kennedy E, Carson DS, Garr DR.

J S C Med Assoc. 2006 Feb;102(1):11-3. No abstract available.

PMID:
16704180
26.

Patients' views of pharmacists as providers of smoking cessation services.

Couchenour RL, Carson DS, Segal AR.

J Am Pharm Assoc (Wash). 2002 May-Jun;42(3):510-2. No abstract available.

PMID:
12030639
27.

Group II metabotropic glutamate receptors modulate extracellular glutamate in the nucleus accumbens.

Xi ZX, Baker DA, Shen H, Carson DS, Kalivas PW.

J Pharmacol Exp Ther. 2002 Jan;300(1):162-71.

PMID:
11752112
28.

Smoking cessation activities in South Carolina community pharmacies.

Couchenour RL, Denham AZ, Simpson KN, Lahoz MR, Carson DS.

J Am Pharm Assoc (Wash). 2000 Nov-Dec;40(6):828-31. No abstract available.

PMID:
11111363
29.

Bisphosphonates in the prevention and treatment of glucocorticoid-induced osteoporosis.

Blair MM, Carson DS, Barrington R.

J Fam Pract. 2000 Sep;49(9):839-48. Review.

PMID:
11032210
31.

Anticoagulant use during lactation.

Shoup J, Carson DS.

J Hum Lact. 1999 Sep;15(3):255-7. No abstract available.

PMID:
10578805
32.

Vitamin E and coronary artery disease.

Spencer AP, Carson DS, Crouch MA.

Arch Intern Med. 1999 Jun 28;159(12):1313-20. Review.

PMID:
10386507
33.

Infertility in women: an update.

Carson DS, Bucci KK.

J Am Pharm Assoc (Wash). 1998 Jul-Aug;38(4):480-6; quiz 487-8. Review.

PMID:
9707958
34.

Optimizing ADHD therapy with sustained-release methylphenidate.

Lawrence JD, Lawrence DB, Carson DS.

Am Fam Physician. 1997 Apr;55(5):1705-9, 1711-2. Review.

PMID:
9105199
35.

Management of obesity: medical treatment options.

Carek PJ, Sherer JT, Carson DS.

Am Fam Physician. 1997 Feb 1;55(2):551-8, 561-2. Review.

PMID:
9054224
36.

Cefuroxime axetil (ceftin): a brief review.

Leder RD, Carson DS.

Infect Dis Obstet Gynecol. 1997;5(3):211-4. No abstract available.

37.

Metformin: a new treatment option for non-insulin-dependent diabetes mellitus.

Goo AK, Carson DS, Bjelajac A.

J Fam Pract. 1996 Jun;42(6):612-8. Review.

PMID:
8656173
38.

Menopause and osteoporosis: the role of HRT.

Carson DS.

J Am Pharm Assoc (Wash). 1996 Apr;NS36(4):234-242, 269.

PMID:
8919598
39.

Calcium-channel blockers and risk of myocardial infarction--more hype than harm.

Phillips BG, MacFarlane LL, Carson DS.

Am J Health Syst Pharm. 1995 Jul 1;52(13):1460-2. No abstract available.

PMID:
7671045
40.

Clinical implications of white coat hypertension.

Carek PJ, Carson DS, Cooke CE, Weart CW.

Am Fam Physician. 1995 Jul;52(1):163-8. Review.

PMID:
7604760
41.

Chronic-pain medications: equivalence levels and method of quantifying usage.

Masters Steedman S, Middaugh SJ, Kee WG, Carson DS, Harden RN, Miller MC.

Clin J Pain. 1992 Sep;8(3):204-14. Review.

PMID:
1421733
42.

Nocturnal leg cramps.

Peters MD 2nd, Carson DS.

DICP. 1990 Jun;24(6):599-600. Review. No abstract available.

PMID:
2193459
43.

Effects of magnesium oxide on the lipid profile of healthy volunteers.

Marken PA, Weart CW, Carson DS, Gums JG, Lopes-Virella MF.

Atherosclerosis. 1989 May;77(1):37-42.

PMID:
2719760
44.

Effect of constant and variable heat on home glucose-testing reagent strips.

Ruffing MJ, Carson DS, Pascal P.

Diabetes Care. 1989 Jan;12(1):41-2. No abstract available.

PMID:
2714168
45.

Ambulatory care pharmacy services at the Family Medicine Center of the Medical University of South Carolina.

Bucci KK, Weart CW, Carson DS, Shaughnessy AF.

Top Hosp Pharm Manage. 1988 Nov;8(3):11-9. No abstract available.

PMID:
10314312
46.

Pyrethrins combined with piperonyl butoxide (RID) vs 1% permethrin (NIX) in the treatment of head lice.

Carson DS, Tribble PW, Weart CW.

Am J Dis Child. 1988 Jul;142(7):768-9.

PMID:
3381781
47.

Infectious diseases in day-care centers: transmission and approaches to prevention.

Carson DS.

Drug Intell Clin Pharm. 1987 Sep;21(9):694-701. Review.

PMID:
3308392
48.

Influence of folk medicine on the family practitioner.

Gums JG, Carson DS.

South Med J. 1987 Feb;80(2):209-12.

PMID:
3810218
49.

Pityriasis lichenoides chronica.

Carson DS.

Arch Dermatol. 1982 Sep;118(9):623-4. No abstract available.

PMID:
7114860

Supplemental Content

Loading ...
Support Center